161 filings
6-K
GNFT
Genfit
29 Feb 24
Current report (foreign)
4:10pm
SC 13G/A
GNFT
Genfit
14 Feb 24
Genfit / TANG CAPITAL PARTNERS ownership change
4:00pm
6-K
GNFT
Genfit
17 Jan 24
GENFIT Announces 2024 Financial Calendar
6:00am
6-K
GNFT
Genfit
11 Jan 24
Current report (foreign)
4:10pm
6-K
GNFT
Genfit
8 Dec 23
Current report (foreign)
8:00am
6-K
1vbih
7 Dec 23
Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC
6:37am
6-K
011uvy7pxj3f0 7n
6 Dec 23
Current report (foreign)
11:30am
6-K
yej0vdorworgm9hne
16 Nov 23
GENFIT Highlights ACLF Development Strategy at “ACLF Day” during AASLD The Liver Meeting® 2023
4:10pm
6-K
vrgj0bpyz5a468xoeg
13 Nov 23
Current report (foreign)
4:30pm
6-K
okhtx0eq02 116cfym9
9 Nov 23
GENFIT Reports Third Quarter 2023 Financial Information
4:10pm
6-K
tm56t
6 Nov 23
GENFIT to Present Update on Scientific and Corporate Progress at The Liver Meeting® 2023
7:00am
6-K
gg1sb tkisofx
26 Sep 23
GENFIT Announces Publication in Nature Medicine Confirming the Performance of its NASH Diagnostic Technology
4:10pm
6-K
8stkupxj 3myd
20 Sep 23
GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update
4:51pm
6-K
1qjfhl8lsudt
20 Sep 23
Current report (foreign)
4:44pm
6-K
zenv47
5 Sep 23
GENFIT to Participate in Upcoming Investor Conferences
4:10pm
6-K
hildr0
10 Aug 23
GENFIT Announces the Publication of New Data on the Clinical Performance of NIS2+™ in Older Patients in Hepatology Communications
4:10pm
6-K
sqp82vgulswt4lshs8p
12 Jul 23
Current report (foreign)
12:00am
6-K
df19er3
30 Jun 23
Current report (foreign)
6:00am
6-K
nw80t zezi6
7 Jun 23
GENFIT Announces New Data at the European Association for the Study of the Liver (EASL) Congress 2023
4:10pm
6-K
6okmekmkv84i2
31 May 23
GENFIT Further Strengthens its ACLF Franchise with a Third Clinical-Stage Asset
4:15pm